Hirsutism laboratory findings: Difference between revisions

Jump to navigation Jump to search
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Hirsutism}}
{{Hirsutism}}
{{CMG}} {{AE}}
{{AE}}


Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.


==Overview==
==Overview{{CMG}}==
It is important to carry out various biochemical tests to determine the cause of hirsutism that is necessary to make an informed decision for the best options for treatment.
It is important to carry out various biochemical tests to determine the cause of hirsutism that is necessary to make an informed decision for the best options for treatment.


==Laboratory Finding==
==Laboratory Finding==
* Testosterone - Serum testosterone may be normal to increased in case of PCOS and CAH but would be definitely raised (>200 ng/ml) in case of malignant tumor of the adrenal or ovary.<ref name="pmid18574213">{{cite journal |vauthors=Lin-Su K, Nimkarn S, New MI |title=Congenital adrenal hyperplasia in adolescents: diagnosis and management |journal=Ann. N. Y. Acad. Sci. |volume=1135 |issue= |pages=95–8 |year=2008 |pmid=18574213 |doi=10.1196/annals.1429.021 |url=}}</ref>
* [[Testosterone]] : Serum testosterone may be normal to increased in case of [[PCOS]] and [[CAH]] but would be definitely raised (>200 ng/ml) in case of [[malignant]] tumor of the [[Adrenal gland|adrenal]] or [[ovary]].<ref name="pmid18574213">{{cite journal |vauthors=Lin-Su K, Nimkarn S, New MI |title=Congenital adrenal hyperplasia in adolescents: diagnosis and management |journal=Ann. N. Y. Acad. Sci. |volume=1135 |issue= |pages=95–8 |year=2008 |pmid=18574213 |doi=10.1196/annals.1429.021 |url=}}</ref>


* Dehydroepiandrosterone sulfate (DHEAS) - Raised DHEAS (>700 μg/dl) always indicates an adrenal cause, benign or malignant.
* [[DHEAS|Dehydroepiandrosterone sulfate (DHEAS)]] : Raised [[DHEAS]] (>700 μg/dl) always indicates an adrenal cause, [[benign]] or [[malignant]].


* 17 Hydroxy progesterone - This serum marker is unique for congenital adrenal hyperplasia. The measurement should be done between 0700 and 0900 hours in the early follicular phase of the menstrual cycle. Levels less than 200 ng/dl excludes the disease. Mildly increased levels between 300 and 1,000 ng/dl require an ACTH stimulation test. Cosyntropin (synthetic ACTH), 250 μg, is administered intravenously, and levels of 17-hydroxyprogesterone are measured before and one hour after the injection. Post-stimulation values (>1,000 ng/dl) constitute a positive test.<ref name="pmid18574213">{{cite journal |vauthors=Lin-Su K, Nimkarn S, New MI |title=Congenital adrenal hyperplasia in adolescents: diagnosis and management |journal=Ann. N. Y. Acad. Sci. |volume=1135 |issue= |pages=95–8 |year=2008 |pmid=18574213 |doi=10.1196/annals.1429.021 |url=}}</ref>
* [[17-Hydroxyprogesterone|17 Hydroxy progesterone]] : Levels less than 200 ng/dl excludes [[CAH]]. Mildly increased levels between 300 and 1,000 ng/dl require an [[ACTH]] stimulation test. [[Cosyntropin]] (synthetic [[ACTH]]), 250 μg, is administered intravenously, and levels of [[17-Hydroxyprogesterone|17-hydroxyprogesterone]] are measured before and one hour after the injection. Post-stimulation values (>1,000 ng/dl) constitute a positive test.<ref name="pmid18574213">{{cite journal |vauthors=Lin-Su K, Nimkarn S, New MI |title=Congenital adrenal hyperplasia in adolescents: diagnosis and management |journal=Ann. N. Y. Acad. Sci. |volume=1135 |issue= |pages=95–8 |year=2008 |pmid=18574213 |doi=10.1196/annals.1429.021 |url=}}</ref>


* Twenty four hour urine free cortisol should be measured in women with signs and symptoms of Cushing's syndrome.
* Twenty four hour urine free [[cortisol]] should be measured in women with signs and symptoms of [[Cushing's syndrome]].


* LH/FSH greater than 3 is indicative of PCOS.<ref name="pmid10352925">{{cite journal |vauthors=Chang RJ, Katz SE |title=Diagnosis of polycystic ovary syndrome |journal=Endocrinol. Metab. Clin. North Am. |volume=28 |issue=2 |pages=397–408, vii |year=1999 |pmid=10352925 |doi= |url=}}</ref>
* [[LH]]/[[FSH]] greater than 3 is indicative of [[PCOS]].<ref name="pmid10352925">{{cite journal |vauthors=Chang RJ, Katz SE |title=Diagnosis of polycystic ovary syndrome |journal=Endocrinol. Metab. Clin. North Am. |volume=28 |issue=2 |pages=397–408, vii |year=1999 |pmid=10352925 |doi= |url=}}</ref>


* Prolactin would be raised in hyperprolactinemia due to hypothalamic disease or a pituitary tumor.
* Serum [[TSH]] and [[Prolactin]]: [[Hypothyroidism]] and [[hyperprolactinemia]] can lead to hirsutism.<ref name="pmid1905280">{{cite journal |vauthors=Schmidt JB, Lindmaier A, Spona J |title=[Hyperprolactinemia and hypophyseal hypothyroidism as cofactors in hirsutism and androgen-induced alopecia in women] |language=German |journal=Hautarzt |volume=42 |issue=3 |pages=168–72 |year=1991 |pmid=1905280 |doi= |url=}}</ref>
 
* Serum TSH: Hypophyseal hypothyroidism[13] can act as a cofactor in hirsutism causing raised TSH.<ref name="pmid1905280">{{cite journal |vauthors=Schmidt JB, Lindmaier A, Spona J |title=[Hyperprolactinemia and hypophyseal hypothyroidism as cofactors in hirsutism and androgen-induced alopecia in women] |language=German |journal=Hautarzt |volume=42 |issue=3 |pages=168–72 |year=1991 |pmid=1905280 |doi= |url=}}</ref>


==References==
==References==

Revision as of 18:56, 15 September 2017

Hirsutism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hirsutism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Echocardiography or Ultrasonography

Treatment

Medical Therapy

Pharmacological therapy
Non-pharmacological therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hirsutism laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hirsutism laboratory findings

CDC on Hirsutism laboratory findings

Hirsutism laboratory findings in the news

Blogs on Hirsutism laboratory findings

Directions to Hospitals Treating Hirsutism laboratory findings

Risk calculators and risk factors for Hirsutism laboratory findings

Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

OverviewEditor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

It is important to carry out various biochemical tests to determine the cause of hirsutism that is necessary to make an informed decision for the best options for treatment.

Laboratory Finding

  • 17 Hydroxy progesterone : Levels less than 200 ng/dl excludes CAH. Mildly increased levels between 300 and 1,000 ng/dl require an ACTH stimulation test. Cosyntropin (synthetic ACTH), 250 μg, is administered intravenously, and levels of 17-hydroxyprogesterone are measured before and one hour after the injection. Post-stimulation values (>1,000 ng/dl) constitute a positive test.[1]

References

  1. 1.0 1.1 Lin-Su K, Nimkarn S, New MI (2008). "Congenital adrenal hyperplasia in adolescents: diagnosis and management". Ann. N. Y. Acad. Sci. 1135: 95–8. doi:10.1196/annals.1429.021. PMID 18574213.
  2. Chang RJ, Katz SE (1999). "Diagnosis of polycystic ovary syndrome". Endocrinol. Metab. Clin. North Am. 28 (2): 397–408, vii. PMID 10352925.
  3. Schmidt JB, Lindmaier A, Spona J (1991). "[Hyperprolactinemia and hypophyseal hypothyroidism as cofactors in hirsutism and androgen-induced alopecia in women]". Hautarzt (in German). 42 (3): 168–72. PMID 1905280.

Template:WH Template:WS